Sawgrass Asset Management LLC Collegium Pharmaceutical, Inc Transaction History

Sawgrass Asset Management LLC

  • $955 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 22, 2021
SELL
$17.83 - $22.29 $286,884 - $358,646
-16,090 Closed
0 $0
Q3 2020

Nov 02, 2020
SELL
$15.78 - $20.82 $82,923 - $109,409
-5,255 Reduced 24.62%
16,090 $335,000
Q2 2020

Jul 27, 2020
BUY
$15.49 - $23.51 $50,265 - $76,289
3,245 Added 17.93%
21,345 $374,000
Q1 2020

May 15, 2020
BUY
$13.89 - $25.45 $251,409 - $460,645
18,100 New
18,100 $296,000

Others Institutions Holding COLL

# of Institutions
254
Shares Held
36.9M
Call Options Held
100K
Put Options Held
21.1K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.12B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Sawgrass Asset Management LLC Portfolio

Follow Sawgrass Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawgrass Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sawgrass Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email